(Q37138028)

18 August 2017

1 reference

title

Microsomal prostaglandin E synthase-1 inhibition in cardiovascular inflammatory disease (English)

1 reference

18 August 2017

0 references

1 reference

1 reference

M Wang

1

1 reference

18 August 2017

W-L Song

series ordinal

2

1 reference

18 August 2017

Y Cheng

series ordinal

3

1 reference

18 August 2017

G A Fitzgerald

series ordinal

4

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

Journal of Internal Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

263

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

500-505

1 reference

Prostaglandins and leukotrienes: advances in eicosanoid biology

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Membrane prostaglandin E synthase-1: a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Role of microsomal prostaglandin E synthase 1 in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Deletion of microsomal prostaglandin E synthase-1 increases sensitivity to salt loading and angiotensin II infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

COX-2-derived prostacyclin confers atheroprotection on female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Prostaglandin E synthases in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Emerging roles of DP and CRTH2 in allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Prostaglandins and adenosine in the regulation of sleep and wakefulness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Is mPGES-1 a promising target for pain therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Clinical significance of prostaglandin E synthase expression in gastric cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2008.01938.X

10.1111/J.1365-2796.2008.01938.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference